Results 31 to 40 of about 2,372 (140)

NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence

Clinical and Translational Medicine, Volume 14, Issue 2, February 2024.
NCAPH significantly influences luminal A breast cancer progression and affects tumour behaviour and treatment response. GSLA10, a gene signature associated with NCAPH, shows promise in predicting luminal A tumour recurrence, demonstrating efficacy alongside existing models such as Oncotype DX.
Marina Mendiburu‐Eliçabe, Natalia García‐Sancha, Roberto Corchado‐Cobos, Angélica Martínez‐López, Hang Chang, Jian Hua Mao, Adrián Blanco‐Gómez, Ana García‐Casas, Andrés Castellanos‐Martín, Nélida Salvador, Alejandro Jiménez‐Navas, Manuel Jesús Pérez‐Baena, Manuel Adolfo Sánchez‐Martín, María Del Mar Abad‐Hernández, Sofía Del Carmen, Juncal Claros‐Ampuero, Juan Jesús Cruz‐Hernández, César Augusto Rodríguez‐Sánchez, María Begoña García‐Cenador, Francisco Javier García‐Criado, Rodrigo Santamaría Vicente, Sonia Castillo‐Lluva, Jesús Pérez‐Losada   +22 more
wiley   +1 more source

Enfermedad hemolítica perinatal Perinatal hemolytic disease

Revista Cubana de Hematología, Inmunología y Hemoterapia, 2000
La enfermedad hemolítica perinatal (EHPN) es una afección inmunológica aloinmune contra antígenos de origen paterno presentes en los hematíes fetales y del recién nacido. Se han reportado numerosos aloanticuerpos dirigidos contra antígenos eritrocitarios
María del Rosario López de Roux, Lázaro Cortina Rosales   +1 more
doaj  

Título y concentración de IgG anti D en la enfermedad hemolítica del feto y el recién nacido Anti-D IgG titer and concentration in the hemolytic disease of the fetus and newborn

Revista Cubana de Hematología, Inmunología y Hemoterapia, 2000
La predicción prenatal de la enfermedad hemolítica del feto y el recién nacido (EHFRN) y la severidad de esta, por métodos no invasivos, es de gran importancia para la adopción temprana de medidas que eviten o minimicen el daño fetal.
María Elena Alfonso Valdés, Víctor H Cortés Rodríguez, Patricia Hernández Díaz, Antonio Bencomo Hernández, Yalile Alfonso Valdés, Girelda Cordero, Sonia Águila, Lisette Orbeal Aldama   +7 more
doaj  

Personalized clinical managements through exploring circulating neural cells and electroencephalography. [PDF]

World J Exp Med, 2023
Mehdipour P, Fathi N, Nosratabadi M.
europepmc   +1 more source

Challenges in interpreting leukocyte and nucleated red blood cell counts in neonatal hemolytic disease: A case report on hematology analyser performance. [PDF]

J Med Biochem
Jakšić M, Banjac L, Banjac B.
europepmc   +1 more source

Assessment of Understandability and Actionability of YouTube Videos on Hemolytic Disease of the Newborn. [PDF]

Cureus, 2023
Chaitanya Kumar IS, Mani A, Sriranjitha T, Muni Srikanth I, Aswathy KV, Bhakta SK, Annapureddy PR, Bojedla SK, Yellamilli HD, Jayam C.   +9 more
europepmc   +1 more source

Severe Neonatal Anemia with Multi-Organ Failure, Extreme Placentomegaly, and Placental Megaloblastic Erythroblastosis as Features in Identifying Congenital Dyserythropoietic Anemia Type 1: A Case Report. [PDF]

Neonatology
Roose O, Gengler C, Stoykova S, Good JM, Tolsa JF, Beauport L.   +5 more
europepmc   +1 more source

Reporting of management and outcomes in the hemolytic disease of the fetus and newborn: a systematic literature review. [PDF]

J Perinatol
Verweij E, Lopriore E, Fitzgibbon M, Noack J, Wilke T, Noel W, van Klink J.   +6 more
europepmc   +1 more source

[Fetal erythroblastosis].

Schweizerische Zeitschrift fur Pathologie und Bakteriologie. Revue suisse de pathologie et de bacteriologie, 2004
M, ISVANESKI, B, JANKOVIC, B, SIMONOVIC
openaire   +3 more sources

Monocyte Monolayer Assay as a Tool in the Early Assessment of the Severity of the Alloantibodies in Patients with Hemolytic Disease of the Fetus and Newborn. [PDF]

Transfus Med Hemother
Santoro D, Ielpi M, Grottola G, Valiente V, Gamboa C, Valencia D, Meller C, Aiello H, Otaño L, Camino P, Burgos Pratx L.   +10 more
europepmc   +1 more source